Skip to main content
Loading…

Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Current session: 13 May 2021 to 14 October 2025
Answer status
Question type

Displaying 45142 questions Show Answers

|

Question reference: S6W-29683

  • Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government which NHS boards prescribe natalizumab (Tysabri) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.

Question reference: S6W-29663

  • Asked by: Nicola Sturgeon, MSP for Glasgow Southside, Scottish National Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Gillian Martin on 18 September 2024

To ask the Scottish Government whether it will provide an update on the implementation of the Scottish Offshore Wind Energy Council’s collaborative framework charter and its development of a strategic investment model.

Question reference: S6W-29627

  • Asked by: Pam Gosal, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government what action it is taking to enhance the education and training of healthcare professionals on hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder (HSD).

Question reference: S6W-29626

  • Asked by: Pam Gosal, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government what action it is taking to establish a pathway of care for individuals with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD).

Question reference: S6W-28513

  • Asked by: Monica Lennon, MSP for Central Scotland, Scottish Labour
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jim Fairlie on 18 September 2024

To ask the Scottish Government what assessment it has made of public transport provision, particularly bus services, for accessing grassroots music venues, in light of reported concerns that a lack of access can negatively impact the sector and the wider small business economy.

Question reference: S6W-29676

  • Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government which NHS boards prescribe alemtuzumab (Lemtrada) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.

Question reference: S6W-29687

  • Asked by: Tim Eagle, MSP for Highlands and Islands, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government which NHS boards prescribe ponesimod (Ponvory) to treat multiple sclerosis (MS); how many patients in each NHS board are receiving this disease modifying therapy, and what its position is on whether it should be prescribed to appropriate patients.

Question reference: S6W-29664

  • Asked by: Nicola Sturgeon, MSP for Glasgow Southside, Scottish National Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Gillian Martin on 18 September 2024

To ask the Scottish Government whether it will list the (a) nature and (b) value of each of the supply chain projects being progressed through the strategic investment model developed by the Scottish Offshore Wind Energy Council and its partners.

Question reference: S6W-29631

  • Asked by: Pam Gosal, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government, regarding hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder (HSD), what discussions it has had with healthcare providers regarding (a) the development of and (b) equipping patients with high-quality self-management tools and resources early in their diagnostic journey, to encourage agency and independence in managing their condition. 

Question reference: S6W-29625

  • Asked by: Pam Gosal, MSP for West Scotland, Scottish Conservative and Unionist Party
  • Date lodged: Friday, 06 September 2024
  • Current Status: Answered by Jenni Minto on 18 September 2024

To ask the Scottish Government what action it is taking to create a coordinated approach for the treatment and care of people with hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD).